These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9207722)

  • 41. Effects of saiboku-to on the survival of human eosinophils.
    Tohda Y; Haraguchi R; Kubo H; Muraki M; Fukuoka M; Nakajima S
    Methods Find Exp Clin Pharmacol; 1999 Jun; 21(5):327-30. PubMed ID: 10420387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human Eosinophils.
    Esnault S; Kelly EA; Shen ZJ; Johansson MW; Malter JS; Jarjour NN
    J Immunol; 2015 Sep; 195(6):2529-39. PubMed ID: 26276876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challenge.
    Ohnishi T; Sur S; Collins DS; Fish JE; Gleich GJ; Peters SP
    J Allergy Clin Immunol; 1993 Oct; 92(4):607-15. PubMed ID: 8409120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory effect of transforming growth factor beta 1 on cytokine-enhanced eosinophil survival and degranulation.
    Atsuta J; Fujisawa T; Iguchi K; Terada A; Kamiya H; Sakurai M
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():31-5. PubMed ID: 7549518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of cetirizine and levocetirizine on two cytokines secretion in human airway epithelial cells.
    Shih MY; Hsu JY; Weng YS; Fu LS
    Allergy Asthma Proc; 2008; 29(5):480-5. PubMed ID: 18926057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM-CSF and inhibition by dexamethasone.
    Xaubet A; Mullol J; López E; Roca-Ferrer J; Rozman M; Carrión T; Fabra JM; Picado C
    Clin Exp Allergy; 1994 Apr; 24(4):307-17. PubMed ID: 8039016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of human eosinophil chemotaxis and adhesion by anti-allergic drugs in vitro.
    Sehmi R; Walsh GM; Hartnell A; Barkans J; North J; Kay AB; Moqbel R
    Pediatr Allergy Immunol; 1993; 4(4 Suppl):13-8. PubMed ID: 8353654
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of TGF-beta on eosinophil chemotaxis.
    Luttmann W; Franz P; Matthys H; Virchow JC
    Scand J Immunol; 1998 Feb; 47(2):127-30. PubMed ID: 9496687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals.
    Warringa RA; Mengelers HJ; Kuijper PH; Raaijmakers JA; Bruijnzeel PL; Koenderman L
    Blood; 1992 Apr; 79(7):1836-41. PubMed ID: 1558975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacological and clinical properties of cetirizine hydrochloride].
    Uchida M; Nakahara H
    Nihon Yakurigaku Zasshi; 2000 Apr; 115(4):229-35. PubMed ID: 10876807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adhesion to fibronectin prolongs eosinophil survival.
    Anwar AR; Moqbel R; Walsh GM; Kay AB; Wardlaw AJ
    J Exp Med; 1993 Mar; 177(3):839-43. PubMed ID: 8436913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells.
    Thomson L; Blaylock MG; Sexton DW; Campbell A; Walsh GM
    Clin Exp Allergy; 2002 Aug; 32(8):1187-92. PubMed ID: 12190657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interferon-gamma induces interleukin-3 release from peripheral blood eosinophils.
    Fujisawa T; Fukuda S; Atsuta J; Ichimi R; Kamiya H; Sakurai M
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):41-3. PubMed ID: 8156003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).
    Leprevost C; Capron M; De Vos C; Tomassini M; Capron A
    Int Arch Allergy Appl Immunol; 1988; 87(1):9-13. PubMed ID: 2971624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine.
    De Vos C; Joseph M; Leprevost C; Vorng H; Tomassini M; Capron M; Capron A
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):212-5. PubMed ID: 2523357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man.
    Fadel R; David B; Herpin-Richard N; Borgnon A; Rassemont R; Rihoux JP
    J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):314-20. PubMed ID: 1976664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of cetirizine on the integrin-dependent respiratory burst of normodense eosinophils.
    Piacentini GL; Mazzi P; Vinco S; Peroni DG; Ferro I; Vicentini L; Boner AL
    J Asthma; 1996; 33(6):417-23. PubMed ID: 8968296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.
    Panousis C; Dhagat U; Edwards KM; Rayzman V; Hardy MP; Braley H; Gauvreau GM; Hercus TR; Smith S; Sehmi R; McMillan L; Dottore M; McClure BJ; Fabri LJ; Vairo G; Lopez AF; Parker MW; Nash AD; Wilson NJ; Wilson MJ; Owczarek CM
    MAbs; 2016; 8(3):436-53. PubMed ID: 26651396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids.
    Cox G; Ohtoshi T; Vancheri C; Denburg JA; Dolovich J; Gauldie J; Jordana M
    Am J Respir Cell Mol Biol; 1991 Jun; 4(6):525-31. PubMed ID: 2054193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevations in granulocyte-macrophage colony-stimulating factor and interleukin-5 levels precede posttreatment eosinophilia in onchocerciasis.
    Hagan JB; Bartemes KR; Kita H; Ottesen EA; Awadzi K; Nutman TB; Gleich GJ
    J Infect Dis; 1996 May; 173(5):1277-80. PubMed ID: 8627086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.